{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:10:19Z","timestamp":1772255419450,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcjo.2015.01.008","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T11:48:17Z","timestamp":1444391297000},"page":"345-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration"],"prefix":"10.1016","volume":"50","author":[{"given":"Gary L.","family":"Yau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2015.01.008_bib1","series-title":"Medical Retina (Essentials in Ophthalmology)","first-page":"67","article-title":"Intravitreal injections: techniques and sequelae","author":"Heimann","year":"2007"},{"key":"10.1016\/j.jcjo.2015.01.008_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib3","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ophtha.2012.08.022","article-title":"Intravitreal ranibizumab for diabetic macular edema with prompt vs deferred laser treatment: 3-year randomized trial results","volume":"119","author":"Elman","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib4","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.ophtha.2012.05.017","article-title":"Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials","volume":"119","author":"Varma","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib5","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.ophtha.2013.05.018","article-title":"A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration","volume":"120","author":"Rasmussen","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/IAE.0b013e3181a91dfd","article-title":"Assessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agents","volume":"29","author":"Seth","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2015.01.008_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajo.2010.04.029","article-title":"Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy","volume":"150","author":"Horsley","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib10","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1167\/iovs.12-9875","article-title":"Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab","volume":"53","author":"Martinez-de-la-Casa","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2015.01.008_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/08820538.2013.771195","article-title":"Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents","volume":"28","author":"Abedi","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ophtha.2011.08.011","article-title":"Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections","volume":"119","author":"Hoang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3129\/i07-172","article-title":"Short-term intraocular pressure changes after intravitreal injection of bevacizumab","volume":"42","author":"Hollands","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ajo.2008.07.007","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.eye.6702938","article-title":"Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab","volume":"23","author":"Bakri","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2015.01.008_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/IAE.0b013e31823f0c95","article-title":"A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab","volume":"32","author":"Wehrli","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2015.01.008_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2009.04.013","article-title":"Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study","volume":"116","author":"Leung","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2015.01.008_bib19","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1167\/iovs.10-5222","article-title":"Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes","volume":"51","author":"Mwanza","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2015.01.008_bib20","first-page":"1073","article-title":"Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration","volume":"6","author":"Nishimura","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2015.01.008_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2013.11.029","article-title":"Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials","volume":"121","author":"Bakri","year":"2014","journal-title":"Ophthalmology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418215000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418215000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:04:55Z","timestamp":1757793895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418215000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0008418215000885"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2015.01.008","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2015.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}